Note s4
121 subscribers
329 photos
69 files
77 links
Download Telegram
Note ๐Ÿ“

๐Ÿ“Œุฌุงุจุชุฑ HF ุณุฑูŠุฑูŠู‡ ุฑุงุจุนู‡

ู‡ุฐุง ุฌุงุจุชุฑ ุทูˆูŠู„ ูƒู„ู„ุด ู ุฑุงุญ ุงุณูˆูŠ ุฌุฒุฆูŠู† ูˆ ุจ ุดูƒู„ ุงุณุฆู„ู‡ โœจุŒุŒ

-ู„ูŠุด ุจุงู„ุถุบุท ูŠูƒูˆู†
thiazide ูˆุญุฏู‡ ูƒุงุงููŠ ุจุณ ุจ HF ู„ุงุฒู… ู†ุถูŠู ูˆูŠุง loop ุŸ
โ€ขู„ุงู†ู‡ thiazide ุงู„ู‡ ุชุงุซูŠุฑ ู‚ูˆูŠ ูƒ anti hypertension ุจุณ ู…ู† ุงุณุชุฎุฏู…ู‡ ุจ HF ูˆุญุฏู‡ ุฑุงุญ ุชู‚ู„ ูุนุงู„ูŠู‡ ู ู„ุงุฒู… ูˆูŠุง loop ูŠุญุณู† ู…ู† ุงู„ูุนุงู„ูŠู‡

-ู„ูŠุด ุงู„ู…ุฏุฑุฑุงุช ู…ุชู‚ู„ู„ ู…ู† ุชุทูˆุฑ ู…ุฑุถ HF ุŸ
โ€ขู„ุงู†ู‡ ุดุบู„ู‡ ู‡ูˆ ุชู‚ู„ูŠู„ ู…ู† ุงุญุชุจุงุณ ุงู„ุณูˆุงุฆู„ ูˆ ุชุณุฎุฏู… ูู‚ุท ููŠ ุญุงู„ู‡ edma

-ู„ูŠุด ู„ุงุฒู… ุงูŠูƒูˆู† ุงู„ู…ุฑูŠุถ Stable ุงู„ู‡ ูŠุงุฎุฐ B-block ุŸ
โ€ขู„ุงู†ู‡ ุนู†ุฏู‡ ุฎุงุตูŠู‡ negative inotropic

-ู„ูŠุด ู„ุงุฒู… ู†ุณุชุฎุฏู… ุนู„ุงุฌุงุช MBC ูู‚ุท ุŸ
โ€ขู„ุงู†ู‡ ู‡ู†ู‡ B-selective

-ูŠุง ุนู„ุงุฌ ูŠุนุชุจุฑ last line ูˆ ูŠู‚ู„ู„ ู…ู† ุฏุฎู‘ู„ ู„ู„ู…ุณุชุดูู‰ุŸ
Digoxin โ€ข

-ูŠุง ุนู„ุงุฌ ูŠุณูˆูŠ anemia ูˆ ู…ูŠู‚ู„ู„ ู…ู† ุฏุฎู„ ุงู„ู…ุณุชุดูู‰ ุŸ
Vericigut โ€ข
#hf
ุนู„ุงุฌุงุช ุงู„ OA..... hip,,knee

1_PAPA=first line
ุจุญุงู„ู‡ ูุดู„ ุงู„ุจุฑุงุณูŠุชู…ูˆู„ ู†ุณุชุฎุฏู…:
2_NASAID

ููŠ ุญุงู„ ูุดู„ ุงู„ุจุฑุงุณูŠุชูˆู„ ูˆุงู„ NASID ู†ุณุชุฎุฏู…

3_INTRA CORTICOSTEROIDS

ู‚ุฏ ู†ุญุชุงุฌ ู„ุฅุถุงูุฉ ู…ูˆุงุฏ ู…ุฎุฏุฑุฉ ู…ุซู„ lidocaine,,,bupivacaine ุฅู„ู‰ ุงู„ูƒูˆุฑุชูŠูƒูˆุณุชูŠุฑูˆูŠุฏ ู„ุฃุฌู„ rapid pain relief

ุจุญุงู„ู‡ ูุดู„ ุงู„ ูƒูˆุฑุชูŠูƒูˆุณุชูŠุฑูˆูŠุฏ ู†ุณุชุฎุฏู…
4_TRAMADOL

5_duloxetine ูŠู…ูƒู† ุงุณุชุฎุฏุงู… ุงู„ ูŠุนุชุจุฑ ุณูƒู†ุฏ ู„ุงูŠู†
ู…ุน ู…ุฑุถู‰ ุงู„ุณูƒุฑูŠ ู„ุฃู†ู‡ ูŠูƒูˆู† neuropathic,,muscleskeletal pain
#oa
ู…ู„ุงุญุธุงุช ู…ู‡ู…ุฉ :
*ูƒู„ ุงู„ุงุฏูˆูŠุฉ ุชู‚ู„ู„ ุงู„ mortality ุจ HF ุจ ุงุณุชุซู†ุงุก
Loop Diuretics
Thiazide
Digoxin

*ุงู„ุงุฏูˆูŠุฉ ุงู„ูŠ ุงฺฏุฏุฑ ุงุณุชุฎุฏู…ู‡ุง ููŠ ุญุงู„ ุงู„ุดุฎุต ุนู†ุฏู‡ resistant hypertension ู‡ู…ุฉ :
Clonidine
Chlorathidone
Sipronlactone
*ู…ู† ุงู„ู…ุฑูŠุถ ูŠุฃุฎุฐ ุนู„ุงุฌ vericiguat ู…ู…ูƒู† ูŠุตูŠุฑ ุนู†ุฏู‡ anemia

*ููŠ ุนู„ุงุฌ ุงู„ู…ุฑุถ ุงู„ูŠ ูŠูƒูˆู†ูˆู† black patients ู†ุณุชุฎุฏู…
CCB
Thiazide

hydralazine/nitrates
ู„ู„ู…ุฑุถู‰ ุงู„ูŠ ูŠูƒูˆู†ูˆู†
black patients with HFrEF
ู…ู…ูƒู† ู…ูŠฺฏูˆู„ black patients ู…ู…ูƒู† ูŠฺฏูˆู„ African American

*ุงู„ุงุฏูˆูŠุฉ ุงู„ูŠ ู…ูˆุตู‰ ุจ ุงุณุชุฎุฏุงู…ู‡ุง ุจ B_ blockers ู„ู…ุฑุถู‰ HF ู‡ูŠ :
Carvedilol
Metoprolol succinate
Bisoprolo
ูˆุงุณุชุฎุฏู… B_blocker ุงุฐุง ูƒุงู† ุงู„ุดุฎุต stable ูŠุนู†ูŠ HFrEF ุจุณ ู…ุงุนู†ุฏู‡ fluid retention

*ุงู„ุงุฏูˆูŠุฉ ุงู„ูŠ ู…ูˆุตู‰ ุจ ุงุณุชุฎุฏุงู…ู‡ุง ุจุนุงุฆู„ุฉ ุงู„ ARBs ู‡ูŠ :
Candesartan
Valsartan
Losartan

*ูˆู…ู† ู†ุฑูŠุฏ ู†ุจุฏู„ ACE inhibitors ูˆุชุณุชุฎุฏู… ุจู…ูƒุงู†ู‡ุง ARNi ู„ุงุฒู… ู†ูˆู‚ู ุงุณุชุฎุฏุงู… ACE ูˆุจุนุฏ 36 ุณุงุนุฉ ู†ุณุชุฎุฏู… ุงู„ ARNi ุจูŠู†ู…ุง ุจ ARBs ู…ุงูƒูˆ ูˆู‚ุช

*ุงู„ thiazide ูˆุญุฏู‡ ู…ุง ุงฺฏุฏุฑ ุงุณุชุฎุฏู…ู‡ ู„ู„ HF ู„ุงู† ู…ูˆ ูุนุงู„ ูƒูุงูŠุฉ ู„ุฐู„ูƒ ู„ุงุฒู… ุฃุณุชุฎุฏู… ูˆูŠุงู‡ loop Diuretics

*ุงู„ุงุฏูˆูŠุฉ ุงู„ูŠ ุชุฑูุน ุงู„ุถุบุท ุฑูƒุฒูˆุง ุนู„ูŠู‡ุง ..
*goal of BP in normal patients (<130/80)
goal of BP in :
Limited life expectancy
Older patients
high disease burden
<150 or <140

DASH *
ู…ุนู†ุงู‡ุง ุงู‚ู„ู„ ู…ู† ุงุฎุฐ ุงู„ sodium ูˆุงุฒูŠุฏ ุงู„ potassium

*ุงุฐุง ูƒุงู† ุงู„ุดุฎุต ู…ุตุงุจ ุจุงู„ุณูƒุฑูŠ ุจุณ ุจุฏูˆู† albuminuria ู ุงุณุชุฎุฏู… first -line therapy
ูˆุงุฐุง ูƒุงู† ู…ูˆุฌูˆุฏ albuminuria ู ุงุณุชุฎุฏู… ูู‚ุท ACE ุงูˆ ARBs

*ูƒู„ ุงุฏูˆูŠุฉ dihydropyridine ุนุฏู‡ุง positive inotropic effect ุจ ุงุณุชุซู†ุงุก
amlodipine
felodipine
ูŠุณูˆูˆู† negative inotropic effect

*ุงู„ thiazide ูŠุณูˆูŠ hypercalcaemia
ู„ูƒู† loop Diuretics ูŠุณูˆูŠ hypocalcemia

*ุงุฏูˆูŠุฉ ุงู„ B_ blockers ุงู„ูŠ ุนู†ุฏู‡ long half life :
atenolol
nadolol

*ุงู„ preeclampsia ุงูุถู„ ุนู„ุงุฌ ุงู„ู‡ุง ู‡ูˆ ุฅู„ delivery

ู‡ุงูŠ ู…ู„ุงุญุธุงุช ุดูุชู‡ุง ู…ู‡ู…ุฉ ูˆู…ู…ูƒู† ุชุฎุฑุจุท ุจ ุฃูˆู„ ู…ู„ุฒู…ุชูŠู†
#hf
โค1
โ€ข ุจุนุถ ุงู„ุดุบู„ุงุช ุงู„ู…ู…ูŠุฒุฉ ูˆุงู„ู…ู‡ู…ุฉ ุจู…ุญุงุถุฑุฉ ุงู„ุณูƒุฑูŠ !

@Xpharmacist | @Notatbkop
ู„ุง ู†ุญู„ู„ ุฅุฎูุงุก ุฃุณู… ุงู„ู‚ู†ุงุฉ ุจุงู„ุชุญูˆูŠู„ .


๐ŸŸข Insulin : weight gain
๐ŸŸข Thiazolidinediones (TZDs) : wight gain ( fluid retention )
๐ŸŸข Meglitinides : weight gain
๐ŸŸข Sulfonylureas : weight gain (1-2 Kg)
๐Ÿ”ต DPP-4 inhibitors: weight neutrality
๐Ÿ”ด Metformin : weight loss (2-3 Kg)
๐Ÿ”ด GLP-1 RA : weight loss (1-3 Kg)
๐Ÿ”ด Amylin analogous: weight loss
-~~-~~-~~-~~-~~-~~-~~-~~-

๐Ÿ”ปInsulin : Hypoglycemia
๐Ÿ”ปSulfonylureas : Hypoglycemia
๐Ÿ”ปMeglitinides : Hypoglycemia
-~~-~~-~~-~~-~~-~~-~~-~~-
๐ŸŒŒ Insulin: subcutaneously & dry powder
๐ŸŒŒ GLP1RAs : all SC ( except semaglutide orally & SC)
๐ŸŒŒ DPP-4 Inhibitors : oral administration
๐ŸŒŒ Sulfonylureas : orally
๐ŸŒŒ Meglitinides : by mouth with each meal ( Orally )
-~~-~~-~~-~~-~~-~~-~~-~~-
โ€ข Short-acting GLP1RAs : lower PPG levels

โ€ข long-acting GLP1RAs : lower both
FPG and PPG ( with larger effects on FPG)

โ€ข ฮฑ-Glucosidase Inhibitors ( Acarbose & miglitol ) : for patients who are near target A1C levels with near- normal FPG but high PPG levels.

โ€ข SGLT-2 inhibitors : lower both FPG and postprandial glucose (PPG)
-~~-~~-~~-~~-~~-~~-~~-~~-
๐Ÿ‘๏ธ Bevacizumab (used off-label) and ranibizumab : anti-VEGF monoclonal antibodies
๐Ÿ‘๏ธaflibercept : VEGF decoy receptor
-~~-~~-~~-~~-~~-~~-~~-~~-
๐Ÿ’ญ Gastroparesis : metoclopramide or low-dose erythromycin

๐Ÿญ Diabetic diarrhea : doxycycline or
metronidazole or Octreotide

๐Ÿซจ Orthostatic hypotension : mineralocorticoids (eg, fludrocortisone) or adrenergic agonists
(midodrine).

๐Ÿ’ญ Erectile dysfunction : oral phosphodiesterase-5 inhibitor

๐ŸฆถCilostazol : reduce PAD symptoms

๐Ÿงด fenofibrate & omega-3 fatty acid & niacin : for hypertriglyceridemia

๐Ÿซ€low-dose aspirin therapy (75โ€“162 mg
daily) : patients with established ASCVD

๐Ÿ›ต Clopidogrel: in patients allergic to aspirin
ุชุฑุฏูˆู† ู†ุฑุงุฌุน DM
ุงู„ูŠูˆู… ุงู…ุชุญู†ุช ุชุญู…ูŠู„ ุงุฏุนูˆู„ูŠ ุงู†ุฌุญ
โค6๐Ÿ™1
ุงุฑุฌุน ุงู†ุดุฑ ู…ู„ุงุญุถุงุช ุน ุงุฏูˆูŠุฉ!
โค3๐Ÿ‘1๐Ÿ™1
๐Ÿ”–ูŠู„ุง ู†ุฑุงุฌุน ุงูˆู„ ู„ูƒุฌุฑ ู„ู…ุงุฏุฉ ุงู„ูุงุฑู…ุง ุงู„ูˆุฒุงุฑูŠุฉ ู„ู„ู…ุฑุญู„ุฉ ุงู„ุฑุงุจุนุฉ 4๏ธโƒฃ

โžก๏ธAnti-inflammatory drugs

ุฑุงุญ ุชูƒูˆู† ุงู„ู…ุฑุงุฌุนุฉ ุจุดูƒู„ ุงุณุฆู„ุฉ ุณุฑูŠุนุฉ ู†ุฑูƒุฒ ุจูŠู‡ุง ุนู„ู‰ ุงู„ู…ู‡ู…ุงุช ุจู‡ุฐุง ุงู„ู„ูƒุฌุฑ ููŠู„ุง ู†ุจู„ุด ๐Ÿ”ฅ

๐Ÿ”ฃุดู†ูˆ ู‡ูŠ ูˆุธูŠูุฉ ุงู„ Prostaglandins ุŸ

โžก๏ธAcid secretion
โžก๏ธMucus production in the GIT
โžก๏ธUterine contractions
โžก๏ธRenal blood flow

ุจุงู„ุงุถุงูุฉ ุงู„ู‰ ุงู† ู‡ูŠ ุชุทู„ุน ุงุซู†ุงุก โฌ‡๏ธ
Allergic and inflammatory processes

๐Ÿ”ฃุงู„ COX1 ูŠุนุชุจุฑ ุงู„
houskeeping enzyme
ุจุณ ุดู†ูˆ ู‡ูŠ ูˆุธูŠูุชู‡  ุŸ


โžก๏ธPhysiologic Production of prostanoids
โžก๏ธGastric cytoprotection vascular homeostasis
โžก๏ธPlatelet aggregation
โžก๏ธKidney function

๐Ÿ”ฃุงู„ COX2 ูŠุณุจุจ ุฒูŠุงุฏุฉ ุจุงู†ุชุงุฌ ุงู„ Prostanoids
In sites of diseases and  during inflammation
ุจุณ ุจุฃูŠ ู…ูƒุงู† ุจุงู„ุฌุณู…
โ€ผ๏ธ
โฌ‡๏ธ
COX2 is constitively expressed in tissues such as
Brain ๐Ÿง ๐Ÿง 
Kidney
Bone ๐Ÿ’€

๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ

๐Ÿ”ฃ ุทุจุนุง ุงุญู†ุง ุงู„ุงุฏูˆูŠุฉ ู…ุงู„ุชู†ุง ุจู‡ุฐุง ุงู„ุฌุงุจุชุฑ ู‡ูŠ ู…ุฌู…ูˆุนุฉ ุงู„NSAIDs ูุดู„ูˆู† ุฑุงุญ ุชุดุชุบู„ ู‡ุฐู‡ ุงู„ู…ุฌู…ูˆุนุฉ ูˆู‡ู„ ูƒู„ ุงู„ู…ุฌู…ูˆุนุฉ ุญุชุดุชุบู„ ุจู†ูุณ ุงู„ู…ูŠูƒุงู†ุฒู… ุŸ

โžก๏ธAll of the NSAIDs act by inhibiting the COX enzymes that catalyzes the first step is prostanoid biosysnthesis

ูˆู‡ุฐุง ุงู„ุดูŠ ุญูŠู‚ู„ู„ ู…ู† ุชุตู†ูŠุน ุงู„โฌ‡๏ธ
prostaglandin
ุจุงู„ุดูƒู„ูŠู† ู…ุงู„ุชู‡ุง
ุงู„ beneficial ูˆุงู„  unwanted effects

ูˆุทุจุนุง ู…ูˆ ูƒู„ ุงู„ NSAIDS ุญุชุดุชุบู„ ุจู†ูุณ ุงู„ุดูƒู„ ๐Ÿค“
ุงูƒูˆ ุนุฏู†ุง ุนุงุฆู„ุชูŠู† ุนุงุฆู„ุฉ ุชูƒูˆู† โฌ‡๏ธ
โžก๏ธselective COX2
โžก๏ธNon selectiveโžก๏ธact on COX1 + COX2
โœโœโœโœโœโœโœโœโœโœโœ

๐Ÿ”ฃู‡ุณุฉ ู†ุจุฏูŠ ู†ุฑุงุฌุน ุงู„ุงุณุจุฑูŠู† ๐Ÿ’Š

ุดู†ูˆ ุงู„ู…ูŠูƒุงู†ุฒู… ู„ู„ุงุณุจุฑูŠู† ุŸ
*๏ธโƒฃIrreversible acetylates and inactivates cylcooxygenase

*๏ธโƒฃ Diminish formation of PGE2
*๏ธโƒฃInhibit inflammation in arthritis
ู„ูƒู† ู†ู†ุชุจู‡ ู‡ู†ุง ุงู† ู‡ูˆ ู„ุง ูŠูˆู‚ู ุชุทูˆุฑ ุงู„ู…ุฑุถ ูˆู„ุง ูŠุณูˆูŠ remission

ูˆุทุจุนุง ู‡ูˆ ุงู„ู‡ โฌ‡๏ธ
โžก๏ธAnti-inflammatory effect
โžก๏ธAnalgesic effect
โžก๏ธAntipyretic effect
โžก๏ธAnti-platelet effect

โฌ…๏ธุจุณ ุงู„ุณุคุงู„ ุงู† ุดูˆูƒุช ูŠุดุชุบู„ ู…ุถุงุฏ ุงู„ุชู‡ุงุจ ูˆุดูˆูƒุช ูŠุดุชุบู„ ูƒุฎุงูุถ ุญุฑุงุฑุฉ ุŸ

๐Ÿ”ฃThe Salicylates exhibit analgesic activity at low doses

๐Ÿ”ฃAnti-inflammatory only at higher doses

ุชุฐูƒุฑ ๐Ÿ’ก
โžก๏ธTwo 325 mg aspirin ร— 4 times daily produce analgesia

ุจูŠู†ู…ุง โฌ‡๏ธ
โžก๏ธ12 to 20 tablets / day produce analgesic + anti-inflammatory activity

โฌ…๏ธูˆุจุฃูŠ ุฌุฑุนุฉ ุญูŠุดุชุบู„ ูƒ anti-platelet ุŸ๐Ÿ‘€ ุŸุŸ

At low dose ( 75 to 162 mg - commonly 81 mg )

โ™ฆ๏ธUsed as prophylactic to
โžก๏ธReduce risk of recurrent cardiovascular events
โžก๏ธTransient ischemic attack
Stroke
โžก๏ธDeath in pt with history of MI , stroke , TIA

๐Ÿ”ฃุฒูŠู† ุดู†ูˆ ุงู„ุฏูˆุงุก ุงู„ู„ูŠ ู†ุณุชุฎุฏู…ู‡ ู„ู„
Severe pain ??

Ketorolac ๐Ÿ’Š
But for only a short duration โœ…

๐Ÿ”ฃู…ู†ูˆ ุงู„ู…ุฑุถู‰ ุงู„ู„ูŠ ู…ุงู†ูƒุฏุฑ ู†ู†ุทูŠู‡ู… ุงู„ุงุณุจุฑูŠู† ุŸ

Pt less than 19 years with viral infection ( ex: chicken pox ) or influenza

ุจุณ ู„ูŠุด ๐Ÿง
ู„ุงู† ู†ุฎุงู ู…ู† ุงู„ Reye syndrome โœ…

ูˆุจุนุฏ ุงู„ู…ู† ู…ุงู†ูƒุฏุฑ ู†ู†ุทูŠู‡ ุŸ
Pt have Gout โŒโŒ

ู„ูŠุด ุŸ ู„ุงู† ู‡ูˆ ูŠู†ุทุฑุญ ุนู† ุทุฑูŠู‚ ุงู„ urine ูˆู‡ุฐุง ุงู„ุดูŠ ุญูŠุฃุซุฑ ุนู„ู‰ โฌ‡๏ธ
uric acid excretion

ุดู†ูˆ ุงู„ุฏูˆุง ุงู„ู„ูŠ ูŠุชุฏุงุฎู„ ูˆูŠุงู‡ ุŸ
Probencid โŒ Aspirin


##Antiinflammation
๐Ÿ‘1
๐Ÿ” ๐Ÿ”ค๐Ÿ” ๐Ÿ”  2๏ธโƒฃ

๐Ÿ”ฃู‡ู„ ุงู„ Salicylates ูŠุนุจุฑ ุงู„ BBB ูˆุงู„ placenta  ุŸ

Yes , salicylates except diflunisal cross BBB , placenta and absorbed ftom skin
ุฎุงุตุฉ ุงู„ โฌ‡๏ธ
methyl salicylate

๐Ÿ”ฃ ุดูˆูƒุช ูŠูƒูˆู† ุงู„ุงุณุจุฑูŠู† zero order ูˆุดูˆูƒุช first order ุŸ

At low dose โžก๏ธ converted by liver to water soluble compound , rapidly cleared by kideny
First order โœ…
Half life : 3.5 hrs

At anti-inflammatory dose โžก๏ธ( > 4 g /day )
Zero order โœ…
Half life : 15 hrs

๐Ÿ”ฃุงูƒูˆ ุงุฏูˆูŠุฉ ุงุซู†ูŠู† ุงู„ู‡ู…
active metabolite
ู…ู†ูˆ ู‡ู… ุŸ

๐Ÿ’ŠNabumetone
๐Ÿ’ŠSulindac

ูˆูŠุทู„ุนูˆู† ุนู† ุทุฑูŠู‚ ุงู„ urine โœ…

ุชุฐูƒุฑ ๐Ÿ’ก
ุงู„ NSAIDS ู„ุงุฒู… ู†ุณุชุฎุฏู…ู‡ุง ุจุงู‚ู„ ุฌุฑุนุฉ ูˆู„ุงู‚ุฑ ูุชุฑุฉ ู…ู…ูƒู†ุฉ ๐Ÿ™‚

๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ

๐Ÿ”ฃู‡ุณุฉ ู†ุฑุงุฌุน ุงู„ Side effects ู„ูƒู„ ุงู„ NSAIDs

๐Ÿ”ขGastrointestinal

ุทุจุนุง ู‡ุงูŠ ุงุดู‡ุฑ ุดูŠ ู„ู‡ุงูŠ ุงู„ู…ุฌู…ูˆุนุฉ ูˆู‡ุฐุง ุงู„ุดูŠ ู…ู…ูƒู† ูŠูƒูˆู† ุจุณูŠุท ู…ุซู„ ุงู„ dyspepsia
ูˆู…ู…ูƒู† ูŠูˆุตู„ ู„ู„ bleeding


๐Ÿ”ฃุฒูŠู† ู…ู†ูˆ ุจูŠู‡ู… ุงู„ุงูƒุซุฑ ุชุฃุซูŠุฑ ุนู„ู‰ ุงู„ GI ๐Ÿ˜

ุงู„ุงุฏูˆูŠุฉ ุงู„ู„ูŠ ุชุดุชุบู„ ุนู„ู‰ COX1 ู‡ูŠ ุงู„ุงูƒุซุฑ ุชุฃุซูŠุฑ ุงู„ GI ู„ุงู† ู‡ูŠ ุญุชู…ู†ุน ุชุตู†ูŠุน ุงู„ โฌ‡๏ธ

PGI2  โžก๏ธInhibit gastric acid secretion

PGE2 & PGF2 a โžก๏ธ
ูˆุทุจุนุง ู‡ุงูŠ ูˆุธูŠูุชู‡ู… ุงู† ูŠุญู…ูˆู† ุงู„ู…ุนุฏุฉ ูˆุงู„ุงู…ุนุงุก ุนู† ุทุฑูŠู‚ ุงูุฑุงุฒ ุงู„ mucus
ูˆู‡ู†ุง ุงุญู†ุง ุฏู†ุซุจุท ุชุตู†ูŠุนู‡ุง ูุจุงู„ุชุงู„ูŠ ุฏุชุฃุซุฑ ู‡ุฐู‡ ุงู„ุงุฏูˆูŠุฉ ุนู„ู‰ ุงู„GI

ุจูŠู†ู…ุง ุงู„ COX2 inhibitor ู‡ุฐู‡ ุงู‚ู„ ุชุฃุซูŠุฑ ุนู„ู‰ ุงู„ GI โœ…

ูˆุทุจุนุง ู…ุงู†ู†ุณู‰ ุงู† ูƒู„ ุงุฏูˆูŠุฉ ุงู„ NSAIDS ู„ุงุฒู… ู†ุงุฎุฐู‡ุง ุจุนุฏ ุงู„ุงูƒู„ ๐ŸŸ๐Ÿ•๐Ÿ”๐ŸŒฏ๐ŸŒญ


๐Ÿ”ฃุฒูŠู† ุงุฐุง ุงู„ู…ุฑูŠุถ ุนู†ุฏู‡ risk ุนุงู„ูŠ ู„ู„ุงุตุงุจุฉ ุจุงู„ GI side effect
ุดู†ุณุชุฎุฏู… ุจู‡ุฐู‡ ุงู„ุญุงู„ุฉ ุŸ


๐Ÿ’ŠPPi or Misoprostol โœ…
Should be used with NSAIDs

๐Ÿ”ขIncreased risk of bleeding


ู„ุงุฒู… ู…ุงู†ู†ุณู‰ ุงู† ุงุฐุง ู…ุฑูŠุถ ุญูŠุณูˆูŠ ุนู…ู„ูŠุฉ ู„ุงุฒู… ูŠูˆู‚ู ุงู„ุงุณุจุฑูŠู† ู‚ุจู„ ุงุณุจูˆุน๐Ÿ“†  ู„ุงู† ู‡ูˆ ูŠุฑุชุจุท ุจุงู„ุตููŠุญุงุช ุจุดูƒู„ irreversible ูŠุนู†ูŠ ุญูŠู…ู†ุน โฌ‡๏ธ

Aggregation for lifetime of the platelet ( 3 to 7 days )

ุชุฐูƒุฑ ๐Ÿ’ก
ุงุฐุง ู†ุฑูŠุฏ ู†ู†ุทูŠ ุงุณุจุฑูŠู† ู…ุน ุงูŠ ุฏูˆุง ุซุงู†ูŠ ู…ู† ู…ุฌู…ูˆุนุฉ ุงู„ NSAIDs ู„ุงุฒู… ู†ู†ุทูŠ ุงู„ุงุณุจุฑูŠู… ู‚ุจู„ ุจู†ุต ุณุงุนุฉ
๐Ÿ”ขRenal effects


NSAIDs lead to acute kidney injury ๐Ÿคซ


๐Ÿ”ข Cadiac effects


ู…ู†ูˆ ุงู„ุงุฎุทุฑ ุนู„ู‰ ุงู„ู‚ู„ุจ ๐Ÿซ€ โ€ผ๏ธ
Selective COX2 inhibitor โŒโŒ

ู…ู†ูˆ ุฃุฃู…ู† ูˆุงุญุฏ ุนู„ู‰ ุงู…ุฑุงุถ ุงู„ู‚ู„ุจ โ‰๏ธ
Naproxen


๐Ÿ”ขOther side effects


โžก๏ธCNS side effect โœ…
โžก๏ธhypersensitivity rxn with aspirin in 15% of patients
ูˆุงู„ู†ุงุณ ุงู„ู„ูŠ ุนุฏู‡ู… ุชุญุณุณ ู„ู„ุงุณุจุฑูŠู† ู„ุงุฒู… ู…ุงู†ู†ุทูŠู‡ู… ุงู„ NSAIDs ุชู…ุงู…ุง โŒโŒ

โžก๏ธ Caution use NSAIDs in asthma patient โŒโŒ

#antinflammation
๐Ÿ‘1
PGs Functions


#NSAID
ูƒ ู…ู„ุฎุตุงุช ุงุถุจุท ุดูŠ ู…ุงู„ ู…ู‚ุจู„ุงุช
ุญุชู‰ ุตู†ุงุนูŠุฉ ุชุงุดูŠุฑ ูุฏ ุดูŠ
๐Ÿ”–ู…ุฑุงุฌุนุฉ ุงู„ู„ูƒุฌุฑ ุงู„ุซุงู†ูŠ ู„ู…ุงุฏุฉ ุงู„ูุงุฑู…ุง ุงู„ูˆุฒุงุฑูŠุฉ

๐Ÿ” ๐Ÿ” ๐Ÿ” 2๏ธโƒฃ

๐Ÿ”ฃุดู†ูˆ ู‡ูŠ ุชุฏุงุฎู„ุงุช ุงู„ Salicylates

๐Ÿ’ŠWarfarin
๐Ÿ’ŠPhenytoin
๐Ÿ’ŠValproic acid

๐Ÿ“ธูƒู„ ู‡ุฐู‡ ุงู„ุงุฏูˆูŠุฉ ุชุญุจ ุชุฑุชุจุท ุจุจุฑูˆุชูŠู†ุงุช ุงู„ุจู„ุงุฒู…ุง ูˆุงู„ salicylate ูƒู„ุด ู‡ู… ูŠุญุจ ูŠุฑุชุจุท ุจุจุฑูˆุชูŠู†ุงุช ุงู„ุจู„ุงุฒู…ุง ูˆุทุจุนุง ู†ู‚ุตุฏ  ุงู„ุงู„ุจูˆู…ูŠู† ูˆุชู‚ุฑูŠุจุง 80-90% ูŠุฑุชุจุท ุจูŠ ๐Ÿ™‚

ูุงู„ู„ูŠ ูŠุตูŠุฑ ุทุจุนุง ุงู† ุงู„ุงุณุจุฑูŠู† ูŠุญู„ ู…ุญู„ ู‡ุฐู‡ ุงู„ุงุฏูˆูŠุฉ ูˆูŠุฑุชุจุท ู‡ูˆ ุจุงู„ุงู„ุจูˆู…ูŠู† ๐Ÿ™‚ู„ุฐู„ูƒ ูƒู„ ู‡ุฐู‡ ุงู„ุงุฏูˆูŠุฉ ุญูŠุฒูŠุฏ ุชุฑูƒูŠุฒู‡ุง ุจุงู„ุฏู… โฌ†๏ธโฌ†๏ธ

๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ

Mild salicylate toxicity
ุดู†ูˆ ู†ุณู…ูŠู‡ุง ุŸ
๐Ÿ‘‰Salicylism
ูˆุดู†ูˆ ุงุนุฑุงุถู‡ุง ุŸ๐Ÿค”

ุงุดูƒุงู„ ูˆุงู„ูˆุงู† ๐Ÿคญ

๐Ÿ‘‰N๐Ÿคข,V๐Ÿคฎ, Headache ๐Ÿค•
๐Ÿ‘‰Hyperventilation
๐Ÿ‘‰Mental confusion ๐Ÿซฅ
๐Ÿ‘‰Dizziness ๐Ÿซจ , tinnitus ๐Ÿ‘‚
๐Ÿ‘‰Restlessness
๐Ÿ‘‰Dilirium
๐Ÿ‘‰Hallucinations
๐Ÿ‘‰Convulsion
๐Ÿ‘‰Coma
๐Ÿ‘‰Respiratory & metabolic acidosis
๐Ÿ‘‰Death from respiratory failure

๐Ÿ”ฃุจุฃูŠ ุญุงู„ุฉ ู†ูƒุฏุฑ ู†ุณุชุฎุฏู… ุงู„ NSAIDs  ุจุงู„ุญุงู…ู„ ุŸ ูˆุดูˆูƒุช ู…ุงู†ูƒุฏุฑ ู†ู†ุทูŠู‡ุง โ€ผ๏ธ

โžก๏ธCan be used only if benefit outweight risk โœ”๏ธ

ูˆู…ุงู†ูƒุฏุฑ ู†ุณุชุฎุฏู…ู‡ุง ุชู…ุงู…ุง ุจุงู„ โŒโŒ โฌ‡๏ธ
Third trimester 

Due to risk of premature closure of ductus arteriosis

โฌ…๏ธุดู†ูˆ ุงู„ุฏูˆุง ุงู„ู„ูŠ ู†ูƒุฏุฑ ู†ุณุชุฎุฏู…ู‡ ุจุงู„ุญุงู…ู„ ูƒู…ุณูƒู† ูˆุฎุงูุถ ุญุฑุงุฑุฉ ุŸ โฌ‡๏ธโฌ‡๏ธ
โžก๏ธAcetaminophen

ู„ู‡ู†ุง ูƒู…ู„ู†ุง ูƒู„ ุดูŠ ูŠุฎุต ุงู„ุงุณุจุฑูŠู† โœ…
ู‡ุณุฉ ู†ู†ุชู‚ู„ ู„ู„ Celecoxib ๐Ÿ”ฅ

๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ

ุจุณ ุงูƒูˆ ู…ุนู„ูˆู…ุฉ ุถุฑูˆุฑูŠ ู†ุฑุงุฌุนู‡ุง ุณุฑูŠุนุง โ€ผ๏ธ

ุงูƒุซุฑ ุฏูˆุง ูŠุดุชุบู„ ุนู„ู‰ COX1 ู‡ูˆ โฌ‡๏ธ
Ketorolac

ุงูƒุซุฑ ุฏูˆุงุก ูŠุดุชุบู„ ุนู„ู‰ COX2 ู‡ูˆ โฌ‡๏ธ
Etodolac

๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ๐Ÿ”ฃ

โžก๏ธCelecoxib  ๐Ÿ’Š
โžก๏ธSelective COX2 inhibitor

ุงู„ Inhibiton ูŠูƒูˆู† reversible ู„ูˆ irreversible ๐Ÿค”

ุชุฐูƒุฑูˆุง ูƒู„ุด ุฒูŠู† ุงู† ุจุณ ุงู„ุงุณุจุฑูŠู† ูŠูƒูˆู† irreversible โœ…โœ…
ุงู„ุจุงู‚ูŠู† ูƒู„ู‡ู… reversible โ˜บ๏ธ

โžก๏ธUses
โžก๏ธRA
โžก๏ธOsteoarthritis
โžก๏ธAcute pain

โฌ…๏ธู‡ู„ ุงูƒูˆ ู…ุฑุถู‰ ู…ุงู†ูƒุฏุฑ ู†ู†ุทูŠู‡ู… ู‡ุฐุง ุงู„ุฏูˆุง ุŸ
ุงูŠ ุงู„ู†ุงุณ ุงู„ู„ูŠ ุนุฏู‡ู… ู…ุดุงูƒู„ ุจุงู„ูƒุจุฏ ุงูˆ ุงู„ูƒู„ู‰ ูˆุชูƒูˆู† ุญุงู„ุชู‡ู… severe
ุชู…ุงู…ุง ู…ุงู†ูƒุฏุฑ ู†ู†ุทูŠู‡ู… Avoided โŒโŒ

ุฒูŠู† ูˆุงุฐุง ุญุงู„ุชู‡ู… moderate โ“โ“
ูŠูƒููŠ ุจุณ ู†ุนุฏู„ ุงู„ุฌุฑุนุฉ โœ…โœ…

Side effects of celecoxib
Headache
Dyspepsia
Diarrhea
Abdominal pain
ู‡ุงูŠ ุงุดู‡ุฑ ุงู„ S.E โœ”๏ธ

ุฒูŠู† ูˆุงู„ GI bleeding ูˆุญุชู‰ ุงู„ dyspepsia ุดู†ูˆ ูˆุถุนู‡ู… ุŸ

ู‚ู„ูŠู„ุฉ ุทุจุนุง ู‡ู†ุง ู…ู‚ุงุฑู†ุฉ ุจุจุงู‚ูŠ ุงุฏูˆูŠุฉ ุงู„ NSAIDs โœ”๏ธ

ุจุณ ู‡ุฐู‡ โฌ†๏ธุงู„ S.E ู…ู…ูƒู† ุชุฒูŠุฏ ูˆู†ุฎุณุฑ ู‡ุฐู‡ ุงู„ู…ูŠุฒุฉ ู„ู„ุฏูˆุง ุงุฐุง ุงุณุชุฎุฏู…ู†ุง ุงู„ุงุณุจุฑูŠู† ูˆูŠุง ุงู„ celecoxib ุงูˆูƒูŠ ู„ุงุชู†ุณูˆู† ๐Ÿค“


ุฒูŠู† ู…ุฑูŠุถ ุนู†ุฏู‡ ulcer ูˆูŠุญุชุงุฌ ูŠุงุฎุฐ ุงุณุจุฑูŠู† ุงูŠ ุฏูˆุง ู„ุงุฒู… ู†ุชุฌู†ุจ ู†ู†ุทูŠู‡ ู„ู„ู…ุฑูŠุถ ู…ู† ู…ุฌู…ูˆุนุฉ ุงู„ NSAIDs ุŸ

Celecoxib should be avoided โŒโŒ
โค1
๐Ÿ”ฃAcetaminophen ๐Ÿ’Š

โžก๏ธ Inhibit Prostaglandin synthesis in CNS โœ…
โžก๏ธ Antipyretic + Analgesic โœ…

โžก๏ธ Weak anti-inflammatory effect
ูŠุนู†ูŠ ู…ุงุนู†ุฏู‡ ุชู‚ุฑูŠุจุง

โžก๏ธ It is not NSAID
โžก๏ธ Dosen't affect platelet function

๐Ÿ”ฃุทูู„ ุนู†ุฏู‡ viral infection ุงูˆ chickenpox ุงู„ู…ุณูƒู† ุงู„ุงูุถู„ ุงู„ู‡ ู‡ูˆ โฌ‡๏ธ

Acetaminophen โœ…โœ…

ู„ุงู† ู…ุงู†ูƒุฏุฑ ู†ุณุชุฎุฏู… ุงู„ุงุณุจุฑูŠู† ู„ุณุจุจ ุงู„ู…ูุฑูˆุถ ู…ุงุชู†ุณูˆู‡ ๐Ÿค“
ุชุฐูƒุฑุชูˆู‡ ุŸ ุนูˆุฏ ูƒุชุจูˆู„ู†ูŠุงู‡ ุจุงู„ุชุนู„ูŠู‚ุงุช ุญุชู‰ ู…ุงุชู†ุณูˆู‡ ๐Ÿ™‚

๐Ÿ”ฃุงู„ acetaminophen ูŠุชุญูˆู„ ุงู„ู‰ ู…ุงุฏุฉ ุชูƒูˆู† โฌ‡๏ธ
Highly reactive metabolite

ูˆุชุชูุงุนู„ ูˆูŠุง ุงู„ sulfhydryl group ูˆุชุณูˆูŠ liver damage

ุนุฑูุชูˆุง ู…ู†ูˆ ู‡ูŠ ุŸ
NAPQI

Side effects of Acetaminophen
โžก๏ธHepatic necrosis

โžก๏ธHepatotoxicity increased with :
โžก๏ธPatient have hepatic disease
โžก๏ธViral hepatitis
โžก๏ธHistory of alcoholism


ุงุฎุฑ ุณุคุงู„ ๐Ÿ™‚
ุดู†ูˆ ู‡ูˆ ุงู„ antidoate
ู„ู„ acetaminophen โ€ผ๏ธ

โžก๏ธN-acetylcysteine
โค1